New Vision International
This article was originally published in The Tan Sheet
Federal Trade Commission approves final order prohibiting firm from making "unsubstantiated" claims regarding effects of its "God's Recipe" product on Attention Deficit Disorder and Attention Deficit-Hyperactivity Disorder. FTC's March 15 vote on the order prohibits the Scottsdale, Ariz.-based dietary supplement company from claiming the product "can cure, prevent, treat or mitigate" the conditions. The proposed order was issued in December ("The Tan Sheet" Dec. 14, 1998, p. 14)
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC